新辅助化疗及间歇性肿瘤细胞减灭术在晚期上皮性卵巢癌中的应用

Application of neoadjuvant chemotherapy and interval cytoreductive surgery in advanced epithelial ovarian cancer

摘要:

新辅助化疗及间歇性肿瘤细胞减灭术逐渐成为晚期上皮性卵巢癌治疗的主流模式之一，但其临床应用中仍有很多问题值得商榷。本文对新辅助化疗在晚期卵巢癌患者中的应用价值及争议等问题进行阐述，以期引起广大妇科肿瘤医师的重视和深入思考，并促进新辅助化疗的合理应用和临床研究。

Abstract:

Neoadjuvant chemotherapy and interval cytoreductive surgery have gradually become one of the mainstream modes for treating advanced epithelial ovarian cancer, but there are still many problems in their clinical application which need to be considered. This article describes the value and controversies of the application of neoadjuvant chemotherapy in patients with advanced ovarian cancer, in order to arouse the attention and in-depth thinking of the majority of gynecological oncologists, and promote the rational application and clinical research of neoadjuvant chemotherapy.